A Study of HS-20094 in Patients With T2DM

NCT06901648 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HS-20094
DRUG: Dulaglutide
DRUG: Palcebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.